Teck Khong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Teck Khong has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Divyen Vanniasegaram
Clinical Pharmacology, St George’s University of London, London, UK
1 shared publication- Hugh Stephen Markus
Clinical Neurosciences, University of Cambridge, Cambridge, UK
1 shared publication Isaac Chung
Blood Pressure Unit, St George’s University Hospitals NHS Trust, London, UK
1 shared publication- James Kimpton
Department of Life Sciences, University of Bath, Bath, UK
1 shared publication Joanna Owens
Freelance Science Writer and Editor, Leicester, UK
1 shared publicationMolly Sharpe
Clinical Pharmacology, City St George’s University of London, London, UK
1 shared publication
Latest Publications
- 10 June 2026
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 64 (7) , 100-102
Once-weekly insulin (insulin efsitora) for patients with type 2 diabetes
Commentary on: Rosenstock J, Bailey T, Connery L, et al . QWINT-1 trial investigators. Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy. N Engl J Med 2025;393:325-35. doi:10.1056/NEJMoa2502796 Series Editor: Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George’s, University of London, UK
- 10 June 2026
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 64 (7) , 100-102
Once-weekly insulin (insulin efsitora) for patients with type 2 diabetes
Commentary on: Rosenstock J, Bailey T, Connery L, et al . QWINT-1 trial investigators. Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy. N Engl J Med 2025;393:325-35. doi:10.1056/NEJMoa2502796 Series Editor: Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George’s, University of London, UK
- 21 October 2025
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 63 (12) , 179-181
Nifedipine or labetalol for hypertension in pregnancy
Commentary on: Sanusi AA, Leach J, Boggess K, et al . Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension. Obstet Gynecol. 2024;144:126-134. Series Editor: Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George’s, University of London, UK
- 21 October 2025
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 63 (12) , 179-181
Nifedipine or labetalol for hypertension in pregnancy
Commentary on: Sanusi AA, Leach J, Boggess K, et al . Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension. Obstet Gynecol. 2024;144:126-134. Series Editor: Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George’s, University of London, UK
- 29 September 2025
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 63 (10) , 146
Orphan drugs—striking the right balance
- 29 September 2025
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 63 (10) , 146
Orphan drugs—striking the right balance
- 15 April 2025
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 63 (7) , 100-102
Targeted-release budesonide for patients with IgA nephropathy
Commentary on: Lafayette R, Kristensen J, Stone A, et al. Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial. Lancet. 2023;402:859–70. Series co-ordinator: Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George’s, University of London, UK
- 15 April 2025
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 63 (7) , 100-102
Targeted-release budesonide for patients with IgA nephropathy
Commentary on: Lafayette R, Kristensen J, Stone A, et al. Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial. Lancet. 2023;402:859–70. Series co-ordinator: Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George’s, University of London, UK
- 9 November 2024
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 63 (2) , 20-21
Adverse effects of antihypertensives in frail older people
- 9 November 2024
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 63 (2) , 20-21
Adverse effects of antihypertensives in frail older people
- 25 August 2020
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 58 (9) , 135-136
Moderate calorie restriction improves cardiometabolic risk factors in healthy individuals
Commentary by: Dr James Kimpton and Dr Teck Khong Clinical Pharmacology, St George's, University of London, UK Series Editor: Dr Teck Khong, DTB Associate Editor Clinical Pharmacology, St George's, University of London, UK Commentary on: Kraus WE, Bhapkar M, Huffman KM, et al. 2 years of calorie restriction and cardiometabolic (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. Lancet Diabetes Endocrinol 2019; 7: 673–83
- 25 August 2020
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 58 (9) , 135-136
Moderate calorie restriction improves cardiometabolic risk factors in healthy individuals
Commentary by: Dr James Kimpton and Dr Teck Khong Clinical Pharmacology, St George's, University of London, UK Series Editor: Dr Teck Khong, DTB Associate Editor Clinical Pharmacology, St George's, University of London, UK Commentary on: Kraus WE, Bhapkar M, Huffman KM, et al. 2 years of calorie restriction and cardiometabolic (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. Lancet Diabetes Endocrinol 2019; 7: 673–83
- Open Access
- 19 March 2008
- Published by Springer Nature in Trials
- Vol. 9 (1) , 15
Community based trial of home blood pressure monitoring with nurse-led telephone support in patients with stroke or transient ischaemic attack recently discharged from hospital
High blood pressure in patients with stroke increases the risk of recurrence but management in the community is often inadequate. Home blood pressure monitoring may increase patients' involvement in their care, increase compliance, and reduce the need for patients to attend their General Practitioner if blood pressure is adequately controlled. However the value of home monitoring to improve blood pressure control is unclear. In particular its use has not been evaluated in stroke patients in whom neurological and cognitive ability may present unique challenges.
- 19 March 2008
- Published by Springer Nature in Trials
- Vol. 9 (1) , 15
Open AccessCommunity based trial of home blood pressure monitoring with nurse-led telephone support in patients with stroke or transient ischaemic attack recently discharged from hospital
High blood pressure in patients with stroke increases the risk of recurrence but management in the community is often inadequate. Home blood pressure monitoring may increase patients' involvement in their care, increase compliance, and reduce the need for patients to attend their General Practitioner if blood pressure is adequately controlled. However the value of home monitoring to improve blood pressure control is unclear. In particular its use has not been evaluated in stroke patients in whom neurological and cognitive ability may present unique challenges.